Alex Zhavoronkov

New Capabilities

As of September 2026: Overseeing the release of the open AI longevity toolkit

Insilico Medicine opened its aging-research AI toolkit to anyone on September 17, 2026. The Cell cover study released LongevityBench, a 17-task benchmark for aging biology, plus Longevity-LLMs, five compact open-source language models trained on multi-omics data (genomics, proteomics, and other biological layers).

Updated Sep 18

New Capabilities

As of September 2026: Leading the company through rentosertib Phase III and the MMAI Gym rollout

Insilico Medicine released AI models Sept. 2 that it says outperform the dedicated software drug companies have used for years. The language-model specialists cover chemical synthesis, drug-safety prediction, and target-binding strength.

Updated Sep 4